Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1983 Jan;71(1):73–80. doi: 10.1172/JCI110753

Hepatic metabolism of 3 alpha-hydroxy-5 beta-etianic acid (3 alpha-hydroxy-5 beta-androstan-17 beta-carboxylic acid) in the adult rat.

J M Little, J St Pyrek, R Lester
PMCID: PMC436839  PMID: 6848561

Abstract

Normal human meconium has been shown to contain short-chain (C20-C22) bile acids and, recently, these compounds have been identified in sera of patients with cholestasis. This suggests that shortchain bile acids may be secreted in bile. We have examined this point by studying the hepatic metabolism and biliary secretion of one naturally occurring C20 bile acid, 3 alpha-hydroxy-5 beta-etianic acid (3 alpha-hydroxy-5 beta-androstan-17 beta-carboxylic acid). [3-3H]-3 alpha-hydroxy-5 beta-etianic acid was prepared and administered intravenously to rats prepared with an external biliary fistula. 85.5 +/- 1.2% of the administered dose was recovered in bile over 20 h with 71.5 +/- 1.3% appearing in the first hour. 11.9 +/- 1.6% of the dose was estimated to be distributed in body water and 0.6 +/- 0.2% was recovered as organic matter in urine. Total recovery of label was 98.0 +/- 2.6%. Administration of milligram quantities of 3 alpha-hydroxy-5 beta-etianic acid produced an increase in bile flow (58.9 +/- 7.1% over basal levels) within 20 min after injection of the steroid. The radiolabeled material in bile was shown by thin-layer chromatography (TLC) to be a polar conjugate which, after beta-glucuronidase hydrolysis, cochromatographed with authentic free 3 alpha-hydroxy-5 beta-etianic acid. After purification, and derivatization, the steroid moiety was proven by gas chromatography-mass spectrometry to be identical to 3 alpha-hydroxy-5 beta-etianic acid. Characterization of the conjugate by TLC and by 3 alpha-hydroxysteroid dehydrogenase assay, before and after beta-glucuronidase hydrolysis, indicated that the steroid was secreted in bile as the 3-O-beta-glucuronide. It is concluded that 3 alpha-hydroxy-5 beta-etianic acid is cleared from the plasma, conjugated with glucuronic acid, and secreted into bile rapidly and in high concentration. The choleretic properties of this shortchain bile acid contrast with the cholestatic effects of lithocholic acid, its C24 analog. Both the form of conjugation of etianic acid and its effect on bile flow suggest that the shortened side chain of this steroid markedly alters its hepatic metabolism and physiology.

Full text

PDF
73

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Admirand W. H., Small D. M. The physicochemical basis of cholesterol gallstone formation in man. J Clin Invest. 1968 May;47(5):1043–1052. doi: 10.1172/JCI105794. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Almé B., Bremmelgaard A., Sjövall J., Thomassen P. Analysis of metabolic profiles of bile acids in urine using a lipophilic anion exchanger and computerized gas-liquid chromatorgaphy-mass spectrometry. J Lipid Res. 1977 May;18(3):339–362. [PubMed] [Google Scholar]
  3. Almé B., Sjövall J. Analysis of bile acid glucuronides in urine. Identification of 3 alpha, 6 alpha, 12 alpha-trihydroxy-5 beta-cholanoic acid. J Steroid Biochem. 1980 Aug;13(8):907–916. doi: 10.1016/0022-4731(80)90164-8. [DOI] [PubMed] [Google Scholar]
  4. Alpert S., Mosher M., Shanske A., Arias I. M. Multiplicity of hepatic excretory mechanisms for organic anions. J Gen Physiol. 1969 Feb;53(2):238–247. doi: 10.1085/jgp.53.2.238. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Back P. Atypische Gallensäuren. Klin Wochenschr. 1980 Jan 15;58(2):55–63. doi: 10.1007/BF01477189. [DOI] [PubMed] [Google Scholar]
  6. Back P. Bile acid glucuronides, II[1]. Isolation and identification of a chenodeoxycholic acid glucuronide from human plasma in intrahepatic cholestasis. Hoppe Seylers Z Physiol Chem. 1976 Feb;357(2):213–217. doi: 10.1515/bchm2.1976.357.1.213. [DOI] [PubMed] [Google Scholar]
  7. Back P., Bowen D. V. Bile acid glucuronides, III[1, 2]. Chemical synthesis and characterization of glucuronic acid coupled mono-, di- and trihydroxy bile acids. Hoppe Seylers Z Physiol Chem. 1976 Feb;357(2):219–224. doi: 10.1515/bchm2.1976.357.1.219. [DOI] [PubMed] [Google Scholar]
  8. Back P., Spaczynski K., Gerok W. Bile-salt glucuronides in urine. Hoppe Seylers Z Physiol Chem. 1974 Jun;355(6):749–752. [PubMed] [Google Scholar]
  9. Back P., Walter K. Developmental pattern of bile acid metabolism as revealed by bile acid analysis of meconium. Gastroenterology. 1980 Apr;78(4):671–676. [PubMed] [Google Scholar]
  10. Bremmelgaard A., Sjövall J. Bile acid profiles in urine of patients with liver diseases. Eur J Clin Invest. 1979 Oct;9(5):341–348. doi: 10.1111/j.1365-2362.1979.tb00894.x. [DOI] [PubMed] [Google Scholar]
  11. Eklund A., Norlander A., Norman A. Bile acid synthesis and excretion following release of total extrahepatic cholestasis by percutaneous transhepatic drainage. Eur J Clin Invest. 1980 Oct;10(5):349–355. doi: 10.1111/j.1365-2362.1980.tb00044.x. [DOI] [PubMed] [Google Scholar]
  12. Eyssen H., Parmentier G., Compernolle F., Boon J., Eggermont E. Trihydroxycoprostanic acid in the duodenal fluid of two children with intrahepatic bile duct anomalies. Biochim Biophys Acta. 1972 Jun 26;273(1):212–221. doi: 10.1016/0304-4165(72)90209-7. [DOI] [PubMed] [Google Scholar]
  13. Hanson R. F., Isenberg J. N., Williams G. C., Hachey D., Szczepanik P., Klein P. D., Sharp H. L. The metabolism of 3alpha, 7alpha, 12alpha-trihydorxy-5beta-cholestan-26-oic acid in two siblings with cholestasis due to intrahepatic bile duct anomalies. An apparent inborn error of cholic acid synthesis. J Clin Invest. 1975 Sep;56(3):577–587. doi: 10.1172/JCI108127. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Javitt N. B. Cholestasis in rats induced by taurolithocholate. Nature. 1966 Jun 18;210(5042):1262–1263. doi: 10.1038/2101262a0. [DOI] [PubMed] [Google Scholar]
  15. Javitt N. B. Hepatic bile formation. (Second of two parts). N Engl J Med. 1976 Dec 30;295(27):1511–1516. doi: 10.1056/NEJM197612302952705. [DOI] [PubMed] [Google Scholar]
  16. Kakis G., Yousef I. M. Pathogenesis of lithocholate- and taurolithocholate-induced intrahepatic cholestasis in rats. Gastroenterology. 1978 Oct;75(4):595–607. [PubMed] [Google Scholar]
  17. Makino I., Sjövall J., Norman A., Strandvik B. Excretion of 3beta-hydroxy-5-cholenoic and 3a-hydroxy-5a-cholanoic acids in urine of infants with biliary atresia. FEBS Lett. 1971 Jun 10;15(2):161–164. doi: 10.1016/0014-5793(71)80047-9. [DOI] [PubMed] [Google Scholar]
  18. Miyai K., Price V. M., Fisher M. M. Bile acid metabolism in mammals. Ultrastructural studies on the intrahepatic cholestasis induced by lithocholic and chenodeoxycholic acids in the rat. Lab Invest. 1971 Apr;24(4):292–302. [PubMed] [Google Scholar]
  19. Miyal K., Mayr W. W., Richardson A. L. Acute cholestasis induced by lithocholic acid in the rat. A freeze-fracture replica and thin section study. Lab Invest. 1975 Apr;32(4):527–535. [PubMed] [Google Scholar]
  20. St Pyrek J., Sterzycki R., Lester R., Adcock E. Constituents of human meconium: II. Identification of steroidal acids with 21 and 22 carbon atoms. Lipids. 1982 Mar;17(3):241–249. doi: 10.1007/BF02535111. [DOI] [PubMed] [Google Scholar]
  21. Summerfield J. A., Billing B. H., Shackleton C. H. Identification of bile acids in the serum and urine in cholestasis. Evidence for 6alpha-hydroxylation of bile acids in man. Biochem J. 1976 Feb 15;154(2):507–516. doi: 10.1042/bj1540507. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. TALALAY P. Enzymic analysis of steroid hormones. Methods Biochem Anal. 1960;8:119–143. doi: 10.1002/9780470110249.ch3. [DOI] [PubMed] [Google Scholar]
  23. Thomassen P. A. Urinary bile acids during development of recurrent cholestasis of pregnancy. Eur J Clin Invest. 1979 Dec;9(6):417–423. doi: 10.1111/j.1365-2362.1979.tb00906.x. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES